A passenger who sailed aboard the expedition cruise ship MV Hondius through Antarctic waters has tested positive for Andes hantavirus after returning home to Canada, making it the fourth country to confirm an infection tied to the vessel. Argentina, the Netherlands, and the United States had already reported cases. The World Health Organization, which has been coordinating the international response since early May 2026, counted 11 confirmed infections across the four nations as of May 13, and the number could still climb as laboratory results trickle in from passengers now scattered across multiple continents.
What makes this cluster unusually alarming is the virus itself. Andes virus is the only hantavirus known to pass directly from one person to another. Every other member of the hantavirus family requires contact with infected rodents or their droppings. That distinction has turned a small shipboard outbreak into a sprawling contact-tracing operation spanning at least four national health systems.
The Canadian case and what officials have confirmed
Canada’s Public Health Agency reported the new case on May 16, 2026. The patient, whose identity has not been disclosed, had returned from the MV Hondius voyage and was already under quarantine with mild symptoms when provincial laboratory testing came back presumptively positive. The National Microbiology Laboratory in Winnipeg subsequently confirmed the result, according to the Associated Press. The European Centre for Disease Prevention and Control noted the confirmation in a situational update the same day.
Canadian health officials said they had begun tracing the patient’s close household and travel contacts but had not identified any secondary infections as of May 18. That negative finding is preliminary; the incubation period for Andes virus can stretch to several weeks, so surveillance will continue well into June 2026.
The WHO’s Disease Outbreak News entry, published May 13, provided the broadest picture of the cluster. It identified the MV Hondius by name, reported 11 confirmed cases, and referenced genomic sequencing work and an epidemiological curve charting when each patient first became ill. The agency did not, however, release the sequence data itself, a gap that independent virologists have flagged as a barrier to assessing whether this strain behaves differently from Andes virus lineages seen in previous outbreaks in southern Argentina and Chile.
How the U.S. is responding
The Centers for Disease Control and Prevention issued a detailed Health Alert Network advisory laying out clinical testing protocols, biosafety precautions, and step-by-step guidance for state and local health departments. A separate briefing transcript released May 15 described how officials are using passenger manifests and airline seating charts to identify people who may have sat near symptomatic travelers on flights home from South America.
That detail is significant. It signals that the CDC is not limiting its concern to what happened aboard the ship. If a passenger was already symptomatic or incubating the virus during a long-haul flight, fellow passengers in nearby seats could theoretically have been exposed in the enclosed cabin environment. The agency has not disclosed how many U.S. residents were on the voyage, how many have been tested, or how many results remain pending.
The CDC’s broader hantavirus situation summary now reflects the MV Hondius cluster. Clinicians across the country are being urged to ask about recent cruise travel in South America when evaluating patients who present with fever, gastrointestinal complaints, and rapidly worsening respiratory distress, the hallmarks of hantavirus pulmonary syndrome.
What Andes virus does to the body
Hantavirus pulmonary syndrome typically begins with fever, muscle aches, and fatigue that can easily be mistaken for the flu. Within days, fluid floods the lungs as capillaries become abnormally permeable, a process that can progress to severe respiratory failure and cardiovascular shock. There is no antiviral drug approved for hantavirus infections and no vaccine. Treatment is supportive: oxygen, mechanical ventilation, and in the most critical cases, extracorporeal membrane oxygenation (ECMO) to keep blood oxygenated while the lungs recover.
Fatality rates for Andes virus infections have historically varied widely, ranging from roughly 20 percent to over 40 percent depending on the strain and how quickly patients reach intensive care. Whether any of the 11 confirmed cases in this cluster have progressed to severe cardiopulmonary syndrome or death has not been stated in any document released by the WHO, CDC, or ECDC as of May 18, 2026. That silence makes it impossible to calculate a case fatality rate for this particular outbreak.
Key questions still unanswered
The most consequential unknown is how the virus got aboard the ship in the first place. Andes virus circulates in wild rodent populations across parts of South America, particularly among long-tailed pygmy rice rats. None of the publicly available summaries describe confirmed rodent infestations on the MV Hondius or at shore excursion sites along the vessel’s route. If the index case acquired the virus from a rodent exposure on land and then passed it to fellow passengers in the ship’s close quarters, the outbreak follows a pattern already documented in rural Argentine and Chilean communities. If, on the other hand, multiple passengers were independently exposed to rodents, the person-to-person narrative would need to be reconsidered.
The exact exposure windows for the Canadian patient remain undisclosed. Officials have not said whether the individual likely caught the virus through direct contact with a symptomatic passenger, through shared air in enclosed ship spaces like dining halls or cabins, or through an initial environmental exposure on shore. That distinction shapes how aggressively health departments need to trace secondary contacts now that the patient is back in a Canadian community.
Full genomic sequence data and phylogenetic analysis from the cluster have not been published, even though the WHO report references such work. Without those sequences, researchers cannot determine whether the circulating strain carries mutations that might alter how easily it spreads or how severe the resulting illness tends to be. Earlier research on person-to-person Andes virus transmission, including a well-known cluster investigation published in the New England Journal of Medicine in 2005, established the biological plausibility of human-to-human spread but involved different viral lineages in different settings.
Why a cruise ship changes the calculus
Cruise ships have a well-documented history of amplifying infectious disease outbreaks. Shared ventilation systems, buffet lines, communal lounges, and small cabins concentrate people in ways that multiply opportunities for close contact. Norovirus, influenza, and COVID-19 all exploited those conditions in high-profile shipboard outbreaks over the past two decades.
If investigators ultimately determine that multiple generations of Andes virus transmission occurred aboard the MV Hondius, meaning the virus jumped from person to person to person rather than spreading only from a single source case, it would represent a meaningful expansion of what scientists understand about this pathogen’s behavior in confined travel environments. That finding would carry implications not just for cruise operators but for any setting where large groups share enclosed air for extended periods.
At the same time, 11 confirmed cases dispersed across four countries, while serious, does not on its own prove the virus has fundamentally changed. The pattern so far, close-contact spread among a defined group with intensive follow-up, remains consistent with what researchers already knew about Andes virus biology. Caution cuts both ways: it is too early to sound an alarm about a new pandemic threat, but also too early to dismiss the cluster as a contained curiosity.
What happens next
Health agencies in all four affected countries are continuing to monitor passengers from the MV Hondius voyage. The incubation period for Andes virus can last up to five or six weeks, which means new cases could still surface through late June 2026. Genomic sequencing results, when they are released publicly, will be the single most important piece of evidence for understanding whether this strain poses risks beyond what has been seen before.
For the general public, the risk remains tightly concentrated among people with direct ties to the voyage or close contact with confirmed cases. No health agency has recommended broad travel restrictions or changes to daily routines. The CDC and ECDC are instead focused on targeted measures: tracing passengers, monitoring symptoms, and making sure clinicians who encounter unexplained febrile respiratory illness think to ask about recent South American travel or contact with returning cruise passengers.
The release of outcome data, whether patients have recovered, remain hospitalized, or died, will fill the most urgent gap in the public record. Until that information arrives, the outbreak sits in an uncomfortable middle ground: clearly serious enough to mobilize four national health systems and the WHO, but still too early in its arc to fully characterize.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
